semaglutide effectiveness without dietary changes Long-term weight loss effects of in obesity diabetes in the SELECT trial Why Am I Not Losing

Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer)

Newsletter Signup

Building sustainable nutrition and lifestyle habits remains foundational to lasting metabolic health, whether someone chooses to take a GLP-1 or not

doi: 10.1016/S0928-4257(99)00119-9

The approval was supported by results from the SURMOUNT-OSA trial that revealed Zepbound led to a significant reduction in the apnea-hypopnea index at 52 weeks compared to placebo in individuals who were and were not receiving PAP therapy

Recalls & Warnings April 21, 2011 FTC Targets Fake News Sites Making Deceptive Acai Claims On April 19, 2011, the Federal Trade Commission (FTC) requested federal courts to temporarily halt the allegedly deceptive tactics of 10 operations using fake news websites to market acai berry weight-loss products